Biography:
Gwen Wise-Blackman, Ph.D. has over 20 years of combined experience in Cell-Based Assays and Quality Systems. She has worked at DuPont Pharmaceuticals, Catalent Pharma Solutions (formerly Magellan Laboratories and Cardinal Health), and Salix Pharmaceuticals where she successfully managed multiple projects and held positions of increasing accountability for scientific and quality expertise. Currently, she is the owner of Gwen Wise-Blackman Consulting, LLC, a biopharmaceutical consulting firm.
Her focus has been on High-Throughput Screening, Cell-Based Assay Method Development and Validation, Ligand Binding Methods, Technology Transfer, GxP Regulations, Training, Auditing, and Quality Assurance.
Dr. Wise-Blackman has a Bachelor of Science degree in biology from M.I.T and a Ph.D. in Pharmacology from the University of Virginia. She is a member of ASQ and AAPS.
